The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs

Background: Gene replacement therapy (GRT) is a treatment method used to combat or prevent various diseases. Its high one-off cost constitutes a major obstacle for successful market access. This paper aims to assess and discuss the applicability of amortization in models, such as cost-effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Polek, Hubert, Janik, Justyna, Paterak, Ewelina, Dabbous, Monique, Pochopień, Michał, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334855/
https://www.ncbi.nlm.nih.gov/pubmed/37440980
http://dx.doi.org/10.1080/20016689.2023.2232648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334855/
https://www.ncbi.nlm.nih.gov/pubmed/37440980
http://dx.doi.org/10.1080/20016689.2023.2232648

Ejemplares similares